High-Density Lipoprotein-Related Inflammatory Indices Predict Repeat Revascularization in Coronary Drug-Eluting Stenting

Reference

• Ahmed HM , Miller M , Nasir K et al. Primary low level of high-density lipoprotein cholesterol and risks of coronary heart disease, cardiovascular disease, and death: results from the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 183(10), 875–883 (2016).
   PubMed Web of Science ®Google Scholar
• Stensvold I , Urdal P , Thürmer H , Tverdal A , Lund-Larsen PG , Foss OP . High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur. Heart J. 13(9), 1155–1163 (1992).
   PubMed Web of Science ®Google Scholar
• Fernandes das Neves M , Batuca JR , Delgado Alves J . The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity. Immunology 164(2), 231–241 (2021).
   PubMed Web of Science ®Google Scholar
• Karataş MB , Çanga Y , Özcan KS et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am. J. Emerg. Med. 34(2), 240–244 (2016).
   PubMed Web of Science ®Google Scholar
• Gao J , Lu J , Sha W et al. Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease. Front. Cardiovasc. Med. 9, 1015398 (2022).
   PubMed Web of Science ®Google Scholar
• Luo H , Kou T , Yin L . High-sensitivity c-reactive protein to HDL-C ratio. Int. Heart J. 62(6), 1221–1229 (2021).
   PubMed Web of Science ®Google Scholar
• Lansky A , Chun H , Pietras C , Hussain Y . Refining drug-eluting stent technologies: from engineering to basic science. Eur. Heart J. 42(18), 1770–1772 (2021).
   PubMed Web of Science ®Google Scholar
• Byrne RA , Joner M , Kastrati A . Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur. Heart J. 36(47), 3320–3331 (2015).
   PubMed Web of Science ®Google Scholar
• Brener SJ , Lytle BW , Casserly IP , Ellis SG , Topol EJ , Lauer MS . Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur. Heart J. 27(4), 413–418 (2006).
   PubMed Web of Science ®Google Scholar
• Giustino G , Serruys PW , Sabik JF 3rd et al. Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL Trial. JACC Cardiovasc. Interv. 13(3), 375–387 (2020).
   PubMed Web of Science ®Google Scholar
• Guo X , Shen R , Yan S , Su Y , Ma L . Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc. Diabetol. 22(1), 43 (2023).
   PubMed Web of Science ®Google Scholar
• Ma YC , Zuo L , Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 17(10), 2937–2944 (2006).
   PubMed Web of Science ®Google Scholar
• Shah AD , Bartlett JW , Carpenter J , Nicholas O , Hemingway H . Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study. Am. J. Epidemiol. 179(6), 764–774 (2014).
   PubMed Web of Science ®Google Scholar
• Johannesen CDL , Langsted A , Mortensen MB , Nordestgaard BG . Association between low density lipoprotein and all cause and cause specifc mortality in Denmark: prospective cohort study. BMJ 371, m4266 (2020).
   PubMedGoogle Scholar
• Soehnlein O , Libby P . Targeting inflammation in atherosclerosis – from experimental insights to the clinic. Nat. Rev. Drug Discov. 20(8), 589–610 (2021).
   PubMed Web of Science ®Google Scholar
• Wallace EL , Abdel-Latif A , Charnigo R et al. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am. J. Cardiol. 109(7), 932–940 (2012).
   PubMedGoogle Scholar
• Alfonso F , Coughlan JJ , Giacoppo D , Kastrati A , Byrne RA . Management of in-stent restenosis. EuroIntervention 18(2), e103–e123 (2022).
   PubMed Web of Science ®Google Scholar
• Joner M , Nakazawa G , Finn AV et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J. Am. Coll. Cardiol. 52(5), 333–342 (2008).
   PubMed Web of Science ®Google Scholar
• Hu W , Jiang J . Hypersensitivity and in-stent restenosis in coronary stent materials. Front. Bioeng. Biotechnol. 10, 1003322 (2022).
   PubMed Web of Science ®Google Scholar
• Sakaguchi G , Shimamoto T , Komiya T . Impact of repeated percutaneous coronary intervention on long-term survival after subsequent coronary artery bypass surgery. J. Cardiothorac. Surg. 6, 107 (2011).
   PubMed Web of Science ®Google Scholar
• Palmerini T , Della Riva D , Biondi-Zoccai G et al. Mortality following nonemergent, uncomplicated target lesion revascularization after percutaneous coronary intervention: an individual patient data pooled analysis of 21 randomized trials and 32,524 patients. JACC Cardiovasc. Interv. 11(9), 892–902 (2018).
   PubMed Web of Science ®Google Scholar
• Parasca CA , Head SJ , Milojevic M et al. Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX trial at 5 years. JACC Cardiovasc. Interv. 9(24), 2493–2507 (2016).
   PubMed Web of Science ®Google Scholar
• Pérez-Morga D , Vanhollebeke B , Paturiaux-Hanocq F et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309(5733), 469–472 (2005).
   PubMed Web of Science ®Google Scholar
• Rivera J , Proia RL , Olivera A . The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8(10), 753–763 (2008).
   PubMed Web of Science ®Google Scholar
• Ma X , Han K , Yang L et al. Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Front. Cardiovasc. Med. 8, 755806 (2022).
   PubMedGoogle Scholar
• Cetin MS , Ozcan Cetin EH , Kalender E et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 25(11), 1077–1086 (2016).
   PubMed Web of Science ®Google Scholar
• Ridker PM , Everett BM , Thuren T et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377(12), 1119–1131 (2017).
   PubMed Web of Science ®Google Scholar
• Tardif JC , Kouz S , Waters DD et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381(26), 2497–2505 (2019).
   PubMed Web of Science ®Google Scholar
• Pasceri V , Patti G , Nusca A et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110(6), 674–678 (2004).
   PubMed Web of Science ®Google Scholar
• Sheikhy A , Fallahzadeh A , Sadeghian S et al. A realistic approach to evaluating the effect of baseline lipid profile in postcoronary artery bypass grafting surgery. Clin. Cardiol. 46(11), 1408–1417 (2023).
   PubMed Web of Science ®Google Scholar
• Rezaee M , Fallahzadeh A , Sheikhy A et al. BMI modifies HDL-C effects on coronary artery bypass grafting outcomes. Lipids Health Dis. 21(1), 128 (2022).
   PubMed Web of Science ®Google Scholar